Latest Stock Split Details
Key information about Yuhan Corporation's most recent stock split
Split Date: 2023-12-27
Split Ratio: 21:20
Price Before Split: $71295.00
Price After Split: $67900.00
Developer API
Get 000100.KS split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/000100.KS
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.05 times more shares (a 21:20 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Yuhan Corporation's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2023-12-27 | 21:20 | No | $71295.00 | $67900.00 |
| 2022-12-28 | 21:20 | No | $60375.01 | $57500.01 |
| 2021-12-29 | 21:20 | No | $66149.93 | $62999.94 |
| 2020-12-29 | 21:20 | No | $77594.84 | $73899.85 |
| 2020-04-08 | 5:1 | No | $232749.33 | $46549.87 |
| 2019-12-27 | 21:20 | No | $248324.25 | $236499.29 |
| 2018-12-27 | 21:20 | No | $215774.16 | $205499.20 |
| 2017-12-27 | 21:20 | No | $228373.88 | $217498.93 |
| 2016-12-28 | 21:20 | No | $209473.78 | $199498.84 |
| 2010-12-29 | 21:20 | No | $178498.77 | $169998.83 |
| 2009-12-29 | 21:20 | No | $185848.49 | $176998.56 |
| 2008-12-29 | 1049971:1000000 | No | $225741.71 | $214998.05 |
| 2007-12-27 | 21:20 | No | $216298.72 | $205998.79 |
| 2006-12-27 | 10499:10000 | No | $185834.85 | $177002.43 |
| 2005-12-28 | 524949:500000 | No | $187409.08 | $178502.18 |
| 2004-12-29 | 21:20 | No | $90720.78 | $86400.75 |
| 2003-12-29 | 21:20 | No | $68707.34 | $65435.56 |
About Yuhan Corporation
Company overview and industry information
Yuhan Corporation (000100.KS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 21-for-20 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Drug Manufacturers - Specialty & Generic
Go to Yuhan Corporation Summary